Competition & Peer Data API & CSV Delivery

Bioage Labs Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Bioage Labs Inc (BIOA) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

1.62 %

Q2 2026

Net Margin

-1,064.75 %

Q2 2026

Key Findings: Bioage Labs Inc vs Its Competitors

TTM: Trailing 12-month revenue of 10M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is decelerating (-5.3% annualized vs trailing 12 months).
Peer revenue share: Bioage Labs Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BIOA Sales vs. its Competitors, Q2 2026

Bioage Labs Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/BIOA/competitors                    

                        https://api.csimarket.com/api/v1/companies/BIOA/relationships                    

                        https://api.csimarket.com/api/v1/companies/BIOA/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs 1.6% for Bioage Labs Inc. Bioage Labs Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

BIOA Stock Performance relative to its Competitors

BIOA Competitors (weighted) Percent change over the selected range

Bioage Labs Inc's Comment on Competition and Industry Peers

The company operates within the biotechnology and pharmaceutical industries, which are characterized by rapid evolution, intense competition, and strong intellectual property protection. It identifies its platform, knowledge, experience, and scientific resources as competitive advantages. The company faces competition from major pharmaceutical and biotechnology firms, academic institutions, governmental agencies, and both public and private research organizations. Its product candidates, if approved, will compete with existing therapies, marketed drugs, and future products targeting metabolic diseases such as obesity. Competitive factors include efficacy, safety, convenience, price, generic alternatives, and reimbursement availability. Many competitors possess greater financial resources and expertise in research, development, manufacturing, clinical trials, regulatory approvals, and marketing, and also compete for qualified personnel and clinical trial sites.

Bioage Labs Inc's Competitiveness

Key Findings: Bioage Labs Inc vs Its Competitors

BIOA Sales vs. its Competitors, Q2 2026

Market Share of the Peer Group, Q2 2026

BIOA Stock Performance relative to its Competitors

Bioage Labs Inc's Comment on Competition and Industry Peers